-
2601
-
2602
-
2603
-
2604
The additive effect of the stress hyperglycemia ratio on type 2 diabetes: a population-based cohort study
Published 2025-01-01Get full text
Article -
2605
-
2606
-
2607
Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients
Published 2017-01-01Get full text
Article -
2608
-
2609
-
2610
Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma
Published 2025-01-01Get full text
Article -
2611
Structural validity and internal consistency of the Patient Centred Assessment Method in a primary care setting in a Japanese island area: a cross-sectional study
Published 2022-06-01“…Objectives The objective of this study was to examine the structural validity and internal consistency of the original English version of the Patient Centred Assessment Method (PCAM) in a primary care setting in a Japanese island area.Design Cross-sectional study.Setting A clinic on a remote island in Okinawa, Japan, that provides general outpatient and 24-hour emergency services.Participants This study included 355 patients who visited Tarama Clinic from 1 April 2018 to 30 June 2018, were aged ≥20 years, lived in Tarama Village and had decision-making capacity.Main outcome measures Patient complexity scored by the PCAM.Results The mean (SD) PCAM score was 21.4 (5.7). …”
Get full text
Article -
2612
Direct Photocoagulation Guided by Merged Retinal Images for the Treatment of Focal Diabetic Macular Edema
Published 2018-01-01Get full text
Article -
2613
-
2614
-
2615
Effectiveness of PK-Guided Personalized Recombinant FVIII Treatment in Patients with Hemophilia A: Clinical Case Experiences Based on an Observational Study
Published 2025-01-01“…Yoko Mizoguchi,1 Moeko Hino,2 Hitoshi Ueda,3 Yasuo Miyaguchi,3 Masao Kobayashi1,4 1Department of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan; 2Department of Pediatrics, Chiba University Hospital, Chiba, Japan; 3Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan; 4Japanese Red Cross, Chugoku-Shikoku Block Blood Center, Hiroshima, JapanCorrespondence: Yasuo Miyaguchi, Japan Medical Office, Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023, Japan, Tel +81 70-4921-7966, Email yasuo.miyaguchi1@takeda.comPurpose: Prophylaxis with recombinant factor VIII (rFVIII) products is the gold-standard treatment for hemophilia A. …”
Get full text
Article -
2616
-
2617
-
2618
Reductions in Muscle Strength and Range of Motion Cause Locomotion Disability via Locomotion-Related Functional Limitation in Japanese Older Adults: A Cross-Sectional Study
Published 2021-01-01“…To assess locomotion disability, the locomotor domain of the activities of daily living (ADLs) survey from the Ministry of Education, Culture, Sports, Science, and Technology of Japan was used. Muscle strength (grip strength) and two ROMs (hip flexion and knee flexion) were measured. …”
Get full text
Article -
2619
-
2620